DR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTEN
0892.402.176 · rovalta.com · 28/09/2026
DR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTEN
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTEN is a Private limited company incorporated in 2007. Its main activity is: Specialist medical practice activities. Its registered office is in Evergem.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0892.402.176
- Incorporation
- 28/09/2007
- Legal form
- Private limited company
- Registered office
- Keizersdreef 15
9940 Evergem · FlandreSee on map - Contributed capital
- 4 711,14 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 18 filingsTrend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 450,1 k € | -1.0% | 454,8 k € | +19.0% | 382,3 k € | +8.7% | 351,7 k € | +19.9% | 293,3 k € |
| EBITDA | 447,8 k € | -0.9% | 452 k € | +18.8% | 380,5 k € | +8.7% | 350 k € | +20.0% | 291,6 k € |
| Operating result | 430 k € | -2.4% | 440,4 k € | +18.2% | 372,8 k € | +7.1% | 348,1 k € | +20.4% | 289 k € |
| Net result | 316,8 k € | +8.9% | 290,8 k € | +12.8% | 257,8 k € | +6.2% | 242,7 k € | +10.9% | 218,9 k € |
| Balance sheet | |||||||||
| Equity | 1 M € | -2.0% | 1 M € | +15.9% | 882,3 k € | +41.3% | 624,5 k € | +26.9% | 491,9 k € |
| Total assets | 1,3 M € | +7.9% | 1,2 M € | +25.1% | 946,6 k € | +24.7% | 759,3 k € | +5.9% | 717 k € |
| Cash | 257,6 k € | +44.2% | 178,7 k € | +141% | 74,2 k € | -85.0% | 496,1 k € | +19.4% | 415,4 k € |
| Debts | 275,6 k € | +71.0% | 161,2 k € | +153% | 63,8 k € | -52.7% | 134,9 k € | -40.1% | 225 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Bart Sierens | Directorsince 03/11/2022bestuurdersince 07/11/2022endedAdministrator - managersince 18/09/2007endedManager18/09/2007 → 31/12/2009ended | |
Kristin Jacobs | Directorsince 03/11/2022bestuurdersince 07/11/2022endedAdministrator - managersince 01/07/2010endedManager01/07/2010 → 31/12/2010ended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/07/2026 | 28/07/2025 | 28/10/2024 | 28/10/2024 | 06/07/2022 | 17/09/2021 |
| General meeting | 28/05/2026 | 29/05/2025 | 30/05/2024 | 25/05/2023 | 27/05/2022 | 27/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 18 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 28/05/2026 | 23/07/2026 | Dutch | |
| Micro model | 31/12/2024 | 29/05/2025 | 28/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 30/05/2024 | 28/10/2024 | Dutch | |
| Micro model | 31/12/2022 | 25/05/2023 | 28/10/2024 | Dutch | |
| Micro model | 31/12/2021 | 27/05/2022 | 06/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 27/05/2021 | 17/09/2021 | Dutch | |
| Micro model | 31/12/2019 | 28/05/2020 | 01/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 31/05/2019 | 28/06/2019 | Dutch | |
| Micro model | 31/12/2017 | 31/05/2018 | 21/09/2018 | Dutch | |
| Abridged model | 31/12/2016 | 26/05/2017 | 18/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 26/05/2016 | 06/10/2016 | Dutch | |
| Abridged model | 31/12/2014 | 28/05/2015 | 09/10/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/05/2014 | 29/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 30/05/2013 | 29/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 31/05/2012 | 06/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 26/05/2011 | 11/06/2011 | Dutch | |
| Abridged model | 31/12/2009 | 27/05/2010 | 08/06/2010 | Dutch | |
| Abridged model | 31/12/2008 | 28/05/2009 | 19/06/2009 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Bart Sierens | Directorsince 03/11/2022bestuurdersince 07/11/2022endedAdministrator - managersince 18/09/2007endedManager18/09/2007 → 31/12/2009ended | |
Kristin Jacobs | Directorsince 03/11/2022bestuurdersince 07/11/2022endedAdministrator - managersince 01/07/2010endedManager01/07/2010 → 31/12/2010ended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other14/10/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates09/11/2022WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Capital / shares20/01/2014KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates16/11/2010BENAMING - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Registered office28/10/2009MAATSCHAPPELIJKE ZETEL
- Other07/01/2008DIVERSEN
- Other08/10/2007RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Keizersdreef 15, 9940 EvergemCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00321300 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTENCurrent | CBE | |
| Dr. B. Sierens - Dr. K. Jacobs | accounts 2025 | Accounts 2025 · 2026-00321300 |
| DR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTEN | accounts 2024 | Accounts 2024 · 2025-00320109 |
| SIERENS BART - JACOBS KRISTIN Drs | accounts 2021 → 2023 | Accounts 2023 · 2024-00521475 |
Events
- 2025Annual accounts 2025316,8 k €↑
- 2025Name changeDr. B. Sierens - Dr. K. Jacobs
- 2024Annual accounts 2024290,8 k €↑
- 2024Name changeDR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTEN
- 2023Annual accounts 2023257,8 k €↑
- 2022Annual accounts 2022242,7 k €↑
- 2021Annual accounts 2021218,9 k €↑
- 2020Annual accounts 2020177,6 k €↑
- 2019Annual accounts 2019130,5 k €↑
- 2018Annual accounts 2018100,3 k €↓
- 2017Annual accounts 2017110,1 k €↓
- 2016Annual accounts 2016169,4 k €↑
- 2015Annual accounts 2015144 k €↑
- 2014Annual accounts 201476,3 k €↓
- 2013Annual accounts 201399,9 k €↓
- 2012Annual accounts 2012110,8 k €↓
- 2011Annual accounts 2011129,5 k €↓
- 2010Annual accounts 2010131,6 k €↓
- 2009Annual accounts 2009151,5 k €↑
- 2008Annual accounts 2008138,2 k €
- 28/09/2007IncorporationPrivate limited company